Ayumi Nishikawa

Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome

Shinya Tasaki, Katsuya Suzuki, Ayumi Nishikawa et al. · Annals of the Rheumatic Diseases · 2017 · 103 citations · Full text

Life Sciences, Immunology, Pathology +17

Brief Report: Leucine‐Rich α₂‐Glycoprotein as a Potential Biomarker for Joint Inflammation During Anti–Interleukin‐6 Biologic Therapy in Rheumatoid Arthritis

Minoru Fujimoto, Satoshi Serada, Katsuya Suzuki et al. · Arthritis & Rheumatology · 2015 · 96 citations

Life Sciences, Immunology, Pharmacotherapy +17

Identification of definitive serum biomarkers associated with disease activity in primary Sjögren’s syndrome

Ayumi Nishikawa, Katsuya Suzuki, Yoshiaki Kassai et al. · Arthritis Research & Therapy · 2016 · 50 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Two cases with autoantibodies to small ubiquitin‐like modifier activating enzyme: A potential unique subset of dermatomyositis‐associated interstitial lung disease

Takahisa Gono, Yoshinori Tanino, Ayumi Nishikawa et al. · International Journal of Rheumatic Diseases · 2019 · 22 citations

Life Sciences, Immunology, Pathology +13

Increased proportion of a CD38highIgD+ B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sjögren's syndrome

Eriko Ishioka-Takei, Keiko Yoshimoto, Katsuya Suzuki et al. · Clinical Immunology · 2017 · 20 citations

Life Sciences, Hematology, Immunology +17